293 related articles for article (PubMed ID: 8062825)
21. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
[TBL] [Abstract][Full Text] [Related]
22. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
Haupt Y; Harris AW; Adams JM
Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
[TBL] [Abstract][Full Text] [Related]
23. Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines.
Ma A; Fisher P; Dildrop R; Oltz E; Rathbun G; Achacoso P; Stall A; Alt FW
EMBO J; 1992 Jul; 11(7):2727-34. PubMed ID: 1628630
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclin D1 in mouse B cell lymphomas of different histologic types and differentiation stages.
Qi CF; Chattopadhyay SK; Lander M; Kim Y; Fredrickson TN; Hartley JW; Morse HC
Leuk Res; 1998 May; 22(5):395-404. PubMed ID: 9652725
[TBL] [Abstract][Full Text] [Related]
25. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
Jadayel D; Matutes E; Dyer MJ; Brito-Babapulle V; Khohkar MT; Oscier D; Catovsky D
Blood; 1994 Jun; 83(12):3664-71. PubMed ID: 8204891
[TBL] [Abstract][Full Text] [Related]
26. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
de Boer CJ; Loyson S; Kluin PM; Kluin-Nelemans HC; Schuuring E; van Krieken JH
Cancer Res; 1993 Sep; 53(18):4148-52. PubMed ID: 8364907
[TBL] [Abstract][Full Text] [Related]
27. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
28. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
29. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
Yang WI; Zukerberg LR; Motokura T; Arnold A; Harris NL
Am J Pathol; 1994 Jul; 145(1):86-96. PubMed ID: 7518196
[TBL] [Abstract][Full Text] [Related]
31. MHC class I expression on prelymphomatous and lymphomatous B-cells is not inhibited by an E mu-myc transgene.
Algarra I; Silva S; Ljunggren HG
Eur J Cancer; 1993; 29A(2):238-41. PubMed ID: 8422288
[TBL] [Abstract][Full Text] [Related]
32. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
33. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.
Nakagawa M; Tsuzuki S; Honma K; Taguchi O; Seto M
Haematologica; 2011 Sep; 96(9):1318-26. PubMed ID: 21606168
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of E mu-myc transgenic mice.
Jacobsen KA; Prasad VS; Sidman CL; Osmond DG
Blood; 1994 Oct; 84(8):2784-94. PubMed ID: 7522642
[TBL] [Abstract][Full Text] [Related]
36. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia.
Robles AI; Larcher F; Whalin RB; Murillas R; Richie E; Gimenez-Conti IB; Jorcano JL; Conti CJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7634-8. PubMed ID: 8755527
[TBL] [Abstract][Full Text] [Related]
37. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.
Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW
EMBO J; 1989 Mar; 8(3):749-55. PubMed ID: 2785918
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]